Aquarius Surgical Technologies Inc.
AQQRF
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.50K | 23.30K | 16.30K | 13.60K | 12.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.50K | 23.30K | 16.30K | 13.60K | 12.70K |
| Cost of Revenue | 5.90K | 9.70K | 8.40K | 6.60K | 5.80K |
| Gross Profit | 6.60K | 13.60K | 7.90K | 7.00K | 6.90K |
| SG&A Expenses | 43.00K | 38.90K | 34.40K | 72.70K | 64.20K |
| Depreciation & Amortization | -- | 0.00 | 1.60K | 4.90K | 4.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.90K | 48.60K | 44.30K | 84.20K | 74.80K |
| Operating Income | -36.40K | -25.40K | -28.10K | -70.60K | -62.10K |
| Income Before Tax | -107.30K | 21.20K | -419.40K | -582.50K | 514.60K |
| Income Tax Expenses | -- | 0.00 | -- | 4.50K | -- |
| Earnings from Continuing Operations | -107.30K | 21.20K | -419.40K | -587.00K | 514.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -107.30K | 21.20K | -419.40K | -587.00K | 514.60K |
| EBIT | -36.40K | -25.40K | -28.10K | -70.60K | -62.10K |
| EBITDA | -- | -23.80K | -26.50K | -65.70K | -61.70K |
| EPS Basic | 0.00 | 0.00 | -0.02 | -0.02 | 0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.02 | -0.02 | 0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M |
| Average Diluted Shares Outstanding | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |